Table 4.

Metabolic Syndrome and Risk of AF: Multivariable Models^*

Variables	HR (95% CI)	P
Metabolic syndrome
NCEP-ATPIII
All subjects	1.88 (1.40–2.52)	<0.001
Subjects without treated hypertension or diabetes>	1.78 (1.07–2.96)	0.03
AHA/NHLBI
All subjects	1.61 (1.21–2.15)	0.001
Subjects without treated hypertension or diabetes	1.28 (0.78–2.1)	0.33
Metabolic syndrome components
Obesity	1.64 (1.26–2.15)	<.001
Elevated blood pressure	1.69 (1.26–2.27)	<0.001
Low HDL cholesterol	1.52 (1.09–2.14)	0.01
Elevated triglycerides	1.13 (0.81–1.57)	0.47
Impaired glucose tolerance (NCEP-ATPIII)	1.44 (1.09–1.90)	0.01
Impaired glucose tolerance (AHA/NHLBI)	1.35 (1.06–1.73)	0.01
Metabolic syndrome components, n
NCEP-ATPIII
0	1.00
1	1.95 (1.30–2.93)	0.001
2	2.05 (1.34–3.15)	0.001
≥3	3.27 (2.10–5.10)	<0.001
Trend across number of components	1.38 (1.21–1.56)	<0.001†
AHA/NHLBI
0	1.00
1	2.33 (1.47–3.72)	<0.001
2	2.54 (1.59–4.07)	<0.001
≥3	3.39 (2.08–5.53)	<0.001
Trend across number of components	1.35 (1.19–1.53)	<0.001†

HR indicates hazard ratio.

^*Models were adjusted for age and gender.

^†Probability value was calculated from a test for trend in 4 groups based on number of fulfilled components.